Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Kala Pharmaceuticals Inc
(NQ:
KALA
)
7.440
USD
+0.080 (+1.09%)
Streaming Delayed Price
Updated: 12:20 PM EST, Mar 2, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
716,487
Open
7.360
Bid (Size)
7.440 (3)
Ask (Size)
7.450 (7)
Prev. Close
7.360
Today's Range
7.270 - 7.540
52wk Range
5.040 - 14.68
Shares Outstanding
24,562,400
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
Today 8:00 EST
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that...
From
Business Wire News Releases
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
February 25, 2021
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported...
From
Business Wire News Releases
Performance
YTD
+8.45%
+8.45%
1 Month
-2.87%
-2.87%
3 Month
-0.27%
-0.27%
6 Month
-16.40%
-16.40%
1 Year
+24.41%
+24.41%
More News
Read More
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
February 18, 2021
From
Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 17, 2021
From
Business Wire News Releases
Kala Pharmaceuticals Announces EYSUVIS™ Now Covered by Express Scripts
February 16, 2021
From
Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
January 20, 2021
From
Business Wire News Releases
Kala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
January 07, 2021
From
Business Wire News Releases
Analysts Expect IEIH Will Reach $39
February 26, 2021
Tags
ETFs
From
ETF Channel
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
January 04, 2021
From
Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
December 18, 2020
From
Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
November 18, 2020
From
Business Wire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.